Elevated C-Reactive Protein in Hidradenitis Suppurativa tied to Severe Disease and Reduced Adalimumab Efficacy: JAMA Medha Baranwal15 Jan 2025 8:45 PM ISTUSA: A recent post hoc analysis of two randomized clinical trials has provided insight into the role of C-reactive protein (CRP) as a potential...
Biocon Biologics announces New Dermatology data to be presented at EADV Congress 2024 Ruchika Sharma25 Sept 2024 2:48 PM ISTBengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd has announced new dermatology data presented at the European Academy of...
Shilpa Medicare arm gets Morocco registration nod for Adalimumab Ruchika Sharma25 July 2024 4:23 PM ISTHyderabad: Shilpa Medicare has announced that Shilpa Biologicals Pvt Ltd (SBPL), a wholly owned subsidiary of the Company has received registration...
Boehringer Ingelheim gets USFDA nod for high-concentration, citrate-free formulation of Cyltezo to treat multiple chronic inflammatory diseases Ruchika Sharma2 May 2024 11:30 AM ISTThe high-concentration formulation (100 mg/mL), which is now available as a pre-filled syringe or pre-filled autoinjector.
Clindamycin and rifampicin addition to adalimumab benefit patients with hidradenitis suppurativa with draining tunnels Medha Baranwal14 Jan 2024 7:00 PM ISTNetherlands: A recent study published in the Journal of the European Academy of Dermatology and Venereology showed improved clinical effectiveness of...
Submit PSUR data: CDSCO Panel Tells Shilpa on additional indication of Rheumatoid Arthritis drug Adalimumab Dr. Divya Colin30 Dec 2023 5:00 PM ISTNew Delhi: In response to the proposal presented by the drug major Shilpa for the extrapolation of indications for Adalimumab 100mg/mL approved in...
Biocon Biologics, Sandoz ink pact for distribution of immune disorder injection Adalimumab in Japan Ruchika Sharma23 Dec 2023 12:30 PM ISTAdalimumab BS for subcutaneous injection [FKB] is a biosimilar of Humira (generic name: adalimumab (genetical recombination)) and is indicated for...
Biocon Biologics's Hulio biosimilar to Humira, now available in US Ruchika Sharma4 July 2023 2:38 PM ISTHULIO is available at a list price (Wholesale Acquisition Cost) of 5% below the current Humira list price.
Adalimumab improves hidradenitis suppurativa outcomes among obese patients Jacinthlyn Sylvia23 May 2023 7:15 PM ISTFor overweight and obese individuals with moderate to severe hidradenitis suppurativa (HS), an increased adalimumab dosage may be linked to better...
Adalimumab and Methotrexate Beneficial for Pediatric Crohn Disease Dr. Shravani Dali4 May 2023 8:00 PM ISTAdalimumab and Methotrexate Beneficial for Pediatric Crohn Disease suggests a new study published in the GastroenterologyTumor necrosis factor...
Sandoz gets European Commission nod for Hyrimoz high-concentration formulation Ruchika Sharma4 April 2023 2:00 PM ISTAdalimumab is a human immunoglobulin G1 (IgG(1)) monoclonal antibody targeting tumor necrosis factor alpha (TNF-a).
Olokizumab superior to placebo and noninferior to adalimumab in RA patients Dr. Shravani Dali22 Sept 2022 8:30 PM ISTIn patients with rheumatoid arthritis who were receiving maintenance methotrexate, olokizumab was superior to placebo and noninferior to adalimumab...
